🚀 VC round data is live in beta, check it out!
Euroapi Valuation Multiples
Discover revenue and EBITDA valuation multiples for Euroapi and similar public comparables like Genovis, Prestige Biologics, Selvita, Savior Lifetec and more.
Euroapi Overview
About Euroapi
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.
Founded
2020
HQ
Employees
3.4K
Website
Financials (LTM)
EV
$84M
Euroapi Financials
Euroapi reported last 12-month revenue of $963M and EBITDA of $76M.
In the same LTM period, Euroapi generated $852M in gross profit, $76M in EBITDA, and had net loss of ($198M).
Revenue (LTM)
Euroapi P&L
In the most recent fiscal year, Euroapi reported revenue of $1B and EBITDA of $77M.
Euroapi expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $963M | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $852M | XXX | $170M | XXX | XXX | XXX |
| Gross Margin | 89% | XXX | 17% | XXX | XXX | XXX |
| EBITDA | $76M | XXX | $77M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | (8%) | XXX | 0% | XXX | XXX | XXX |
| Net Profit | ($198M) | XXX | ($246M) | XXX | XXX | XXX |
| Net Margin | (21%) | XXX | (24%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Euroapi Stock Performance
Euroapi has current market cap of $148M, and enterprise value of $84M.
Market Cap Evolution
Euroapi's stock price is $1.56.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $84M | $148M | -0.1% | XXX | XXX | XXX | $-2.58 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEuroapi Valuation Multiples
Euroapi trades at 0.1x EV/Revenue multiple, and 1.1x EV/EBITDA.
EV / Revenue (LTM)
Euroapi Financial Valuation Multiples
As of April 19, 2026, Euroapi has market cap of $148M and EV of $84M.
Equity research analysts estimate Euroapi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Euroapi has a P/E ratio of (0.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $148M | XXX | $148M | XXX | XXX | XXX |
| EV (current) | $84M | XXX | $84M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBIT | (1.1x) | XXX | 42.2x | XXX | XXX | XXX |
| EV/Gross Profit | 0.1x | XXX | 0.5x | XXX | XXX | XXX |
| P/E | (0.7x) | XXX | (0.6x) | XXX | XXX | XXX |
| EV/FCF | 3.9x | XXX | 1.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Euroapi Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Euroapi Margins & Growth Rates
Euroapi's revenue in the last 12 month declined by (5%).
Euroapi's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.
Euroapi's rule of 40 is (2%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Euroapi's rule of X is (17%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Euroapi Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (5%) | XXX | (10%) | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | (4%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (2%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (17%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 9% | XXX | 9% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Euroapi Public Comps
See public comps and valuation multiples for other Contract Research & Manufacturing comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Euroapi | XXX | XXX | XXX | XXX | XXX | XXX |
| Genovis | XXX | XXX | XXX | XXX | XXX | XXX |
| Prestige Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| Selvita | XXX | XXX | XXX | XXX | XXX | XXX |
| Savior Lifetec | XXX | XXX | XXX | XXX | XXX | XXX |
| Mycenax Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Euroapi M&A Activity
Euroapi acquired XXX companies to date.
Last acquisition by Euroapi was on XXXXXXXX, XXXXX. Euroapi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Euroapi
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEuroapi Investment Activity
Euroapi invested in XXX companies to date.
Euroapi made its latest investment on XXXXXXXX, XXXXX. Euroapi invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Euroapi
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Euroapi
| When was Euroapi founded? | Euroapi was founded in 2020. |
| Where is Euroapi headquartered? | Euroapi is headquartered in France. |
| How many employees does Euroapi have? | As of today, Euroapi has over 3K employees. |
| Is Euroapi publicly listed? | Yes, Euroapi is a public company listed on Euronext Paris. |
| What is the stock symbol of Euroapi? | Euroapi trades under EAPI ticker. |
| When did Euroapi go public? | Euroapi went public in 2022. |
| Who are competitors of Euroapi? | Euroapi main competitors are Genovis, Prestige Biologics, Selvita, Savior Lifetec. |
| What is the current market cap of Euroapi? | Euroapi's current market cap is $148M. |
| What is the current revenue of Euroapi? | Euroapi's last 12 months revenue is $963M. |
| What is the current revenue growth of Euroapi? | Euroapi revenue growth (NTM/LTM) is (5%). |
| What is the current EV/Revenue multiple of Euroapi? | Current revenue multiple of Euroapi is 0.1x. |
| Is Euroapi profitable? | Yes, Euroapi is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Euroapi? | Euroapi's last 12 months EBITDA is $76M. |
| What is Euroapi's EBITDA margin? | Euroapi's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Euroapi? | Current EBITDA multiple of Euroapi is 1.1x. |
| What is the current FCF of Euroapi? | Euroapi's last 12 months FCF is $22M. |
| What is Euroapi's FCF margin? | Euroapi's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Euroapi? | Current FCF multiple of Euroapi is 3.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.